BioNxt Solutions Company Description

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability.

It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications.

The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022.

The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

BioNxt Solutions Inc.

Country	Canada
Founded	2017
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
CEO	Wolfgang Probst

Contact Details

Address: 1820 Fir Street Vancouver, British Columbia V6J 3B1 Canada
Phone	780 818 6422
Website	bionxt.com

Stock Details

Ticker Symbol	BNXT
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA0909741062
SIC Code	2834

Key Executives

Name	Position
Wolfgang Probst	Interim Chief Executive Officer and Director
Patrick Joseph Meagher C.A., CPA, CA, CPA	Chief Financial Officer, Corporate Secretary and Director
Dr. Florian A. Sahr	Head of Project Management